Aftovaxpur DOE (19) O Taiwan 3/97 + A22 Iraq
Aftovaxpur DOE (19) O Taiwan 3/97 + A22 Iraq
Nav atļautas
- Foot-and-mouth disease virus, serotype A, strain O/Taiwan/3/97, Inactivated
- Foot-and-mouth disease virus, serotype A, strain A22 Iraq, Inactivated
Zāļu identifikācija
Sīkāka informācija par zālēm
Farmaceitiskā forma:
-
Emulsija injekcijām
Anatomiski terapeitiski ķīmiskais veterinārais (ATĶvet) kods:
- QI02AA04
Izplatīšanas juridiskie nosacījumi:
-
Recepšu veterinārās zāles
Atļaujas statuss:
-
Atsaukta
Atļautas:
-
Čehija
Papildu informācija
Tiesību tips:
Tirdzniecības atļaujas turētājs:
- Boehringer Ingelheim Vetmedica GmbH
Tirdzniecības atļaujas datums:
Ražošanas vietas sēriju izlaidei:
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
- Boehringer Ingelheim Animal Health France
Atbildīgā iestāde:
- European Commission
Atļaujas numurs:
Šī informācija par šīm zālēm nav pieejama.
Atļaujas statusa maiņas datums:
Lai uzzinātu par veterināro zāļu blakusparādībām, lūdzu, dodieties uz: www.adrreports.eu/vet
Dokumenti
Visu dokumentu apvienotais fails
latviešu (PDF)
Lejupielādēt Publicēts: 14/03/2026
English (PDF)
Publicēts: 14/03/2026
Czech (PDF)
Publicēts: 14/03/2026
Danish (PDF)
Publicēts: 14/03/2026
German (PDF)
Publicēts: 14/03/2026
Greek (PDF)
Publicēts: 14/03/2026
Bulgarian (PDF)
Publicēts: 14/03/2026
Spanish (PDF)
Publicēts: 14/03/2026
Estonian (PDF)
Publicēts: 14/03/2026
Finnish (PDF)
Publicēts: 14/03/2026
French (PDF)
Publicēts: 14/03/2026
Croatian (PDF)
Publicēts: 14/03/2026
Hungarian (PDF)
Publicēts: 14/03/2026
Icelandic (PDF)
Publicēts: 14/03/2026
Italian (PDF)
Publicēts: 14/03/2026
Lithuanian (PDF)
Publicēts: 14/03/2026
Maltese (PDF)
Publicēts: 14/03/2026
Dutch (PDF)
Publicēts: 14/03/2026
Polish (PDF)
Publicēts: 14/03/2026
Romanian (PDF)
Publicēts: 14/03/2026
Slovak (PDF)
Publicēts: 14/03/2026
Slovenian (PDF)
Publicēts: 14/03/2026
Swedish (PDF)
Publicēts: 14/03/2026
Norwegian (PDF)
Publicēts: 14/03/2026
Portuguese (PDF)
Publicēts: 14/03/2026
ema-puar-aftovaxpur-v-2292-par-en.pdf
English (PDF)
Lejupielādēt Publicēts: 14/03/2026
ema-puar-aftovaxpur-v-2292-var-ii-0009-en.pdf
English (PDF)
Lejupielādēt Publicēts: 14/03/2026
ema-puar-aftovaxpur-v-2292-var-ii-0001-en.pdf
English (PDF)
Lejupielādēt Publicēts: 14/03/2026